alopecia faers
Spotting Alopecia Signals: Semaglutide 1.4% vs Tirzepatide 2.3%
Semaglutide triggers alopecia in about 1.4% of users, whereas tirzepatide shows a 2.3% flag rate in the 10-year FAERS review. This finding comes from a comprehensive analysis of the FDA’s Adverse Event Reporting System, highlighting a measurable difference between the two GLP-1 agents. Medical Disclaimer: This article